Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for ARDS-associated Right Ventricular Dysfunction
NCT05768230Phase 3Not yet recruiting
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in Right ventricular dysfunction (RVD). Planned start Mar 2023; status: not yet recruiting.
02
Drugs
levosimendan
03
Conditions
Right ventricular dysfunction (RVD)
Beyond the preview
Go deeper on NCT05768230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05768230.